BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28893776)

  • 1. Mycobacterium tuberculosis Subculture Results in Loss of Potentially Clinically Relevant Heteroresistance.
    Metcalfe JZ; Streicher E; Theron G; Colman RE; Penaloza R; Allender C; Lemmer D; Warren RM; Engelthaler DM
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28893776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Spectrum of Mutations in Genes Associated with Resistance to Rifampicin, Isoniazid, and Fluoroquinolones in the Clinical Strains of M. tuberculosis Reflects the Transmissibility of Mutant Clones].
    Ergeshov A; Andreevskaya SN; Larionova EE; Smirnova TG; Chernousova LN
    Mol Biol (Mosk); 2017; 51(4):595-602. PubMed ID: 28900077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.
    Jnawali HN; Hwang SC; Park YK; Kim H; Lee YS; Chung GT; Choe KH; Ryoo S
    Diagn Microbiol Infect Dis; 2013 Jun; 76(2):187-96. PubMed ID: 23561273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of next-generation sequencing to detect variants of drug-resistant Mycobacterium tuberculosis: genotype-phenotype correlation.
    Ko DH; Lee EJ; Lee SK; Kim HS; Shin SY; Hyun J; Kim JS; Song W; Kim HS
    Ann Clin Microbiol Antimicrob; 2019 Jan; 18(1):2. PubMed ID: 30606210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation.
    Nikolayevsky V; Brown T; Balabanova Y; Ruddy M; Fedorin I; Drobniewski F
    J Clin Microbiol; 2004 Oct; 42(10):4498-502. PubMed ID: 15472300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of genetic determinants of multidrug and extensively drug-resistant Mycobacterium tuberculosis using oligonucleotide microchip].
    Zimenkov DV; Kulagina EV; Antonova OV; Surzhikov SA; Bespiatykh IuA; Shitikov EA; Il'ina EN; Mikhaĭlovich VM; Zasedatelev AS; Griadunov DA
    Mol Biol (Mosk); 2014; 48(2):251-64. PubMed ID: 25850294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Bakuła Z; Napiórkowska A; Kamiński M; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J; Jagielski T
    J Microbiol Immunol Infect; 2016 Jun; 49(3):439-44. PubMed ID: 26117528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quadruple-first line drug resistance in Mycobacterium tuberculosis in Vietnam: What can we learn from genes?
    Nguyen HQ; Nguyen NV; Contamin L; Tran THT; Vu TT; Nguyen HV; Nguyen NLT; Nguyen ST; Dang AD; Bañuls AL; Nguyen VAT
    Infect Genet Evol; 2017 Jun; 50():55-61. PubMed ID: 28214557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan.
    Kozhamkulov U; Akhmetova A; Rakhimova S; Belova E; Alenova A; Bismilda V; Chingissova L; Ismailov S; Ramanculov E; Momynaliev K
    Jpn J Infect Dis; 2011; 64(3):253-5. PubMed ID: 21617314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining Genotypic Drug Resistance by Ion Semiconductor Sequencing With the Ion AmpliSeq™ TB Panel in Multidrug-Resistant Mycobacterium tuberculosis Isolates.
    Park J; Shin SY; Kim K; Park K; Shin S; Ihm C
    Ann Lab Med; 2018 Jul; 38(4):316-323. PubMed ID: 29611381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug-resistant and heteroresistant Mycobacterium tuberculosis and associated gene mutations in Ethiopia.
    Mekonnen D; Admassu A; Mulu W; Amor A; Benito A; Gelaye W; Biadglegne F; Abera B
    Int J Infect Dis; 2015 Oct; 39():34-8. PubMed ID: 26119857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan.
    Hofmann-Thiel S; van Ingen J; Feldmann K; Turaev L; Uzakova GT; Murmusaeva G; van Soolingen D; Hoffmann H
    Eur Respir J; 2009 Feb; 33(2):368-74. PubMed ID: 18829680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of mutations of multidrug-resistant M. tuberculosis strains in patients with tuberculosis in the Kyrghyz Republic].
    Isakova ZhT; Goncharova ZK; Iusupova EU; Tumashova AF; Kozhomkulov MD; Kozhomkulov DK; Chubakov TCh; Alisherov ASh; Aldashev AA
    Probl Tuberk Bolezn Legk; 2007; (4):17-21. PubMed ID: 17657962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid and accurate detection of rifampin and isoniazid-resistant Mycobacterium tuberculosis using an oligonucleotide array.
    Huang WL; Hsu ZJ; Chang TC; Jou R
    Clin Microbiol Infect; 2014 Sep; 20(9):O542-9. PubMed ID: 24372766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypically occult multidrug-resistant Mycobacterium tuberculosis: dilemmas in diagnosis and treatment.
    Ho J; Jelfs P; Sintchencko V
    J Antimicrob Chemother; 2013 Dec; 68(12):2915-20. PubMed ID: 23838950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of rpoB, katG and inhA gene mutations in Mycobacterium tuberculosis clinical isolates from Chongqing as determined by microarray.
    Yao C; Zhu T; Li Y; Zhang L; Zhang B; Huang J; Fu W
    Clin Microbiol Infect; 2010 Nov; 16(11):1639-43. PubMed ID: 20491829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance comparison of four methods for detecting multidrug-resistant Mycobacterium tuberculosis strains.
    Al-Mutairi NM; Ahmad S; Mokaddas E
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):110-5. PubMed ID: 21276306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Conventional and molecular diagnosis in a group of patients with drug-resistant tuberculosis].
    Mindru R; Spînu V; Popa C; Botezatu E; Spătaru R
    Pneumologia; 2014; 63(3):168-73. PubMed ID: 25420292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High proportion of heteroresistance in gyrA and gyrB in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates.
    Eilertson B; Maruri F; Blackman A; Herrera M; Samuels DC; Sterling TR
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3270-5. PubMed ID: 24687490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates from Ontario, Canada.
    Bolotin S; Alexander DC; Chedore P; Drews SJ; Jamieson F
    J Antimicrob Chemother; 2009 Aug; 64(2):263-6. PubMed ID: 19520719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.